On Our Way To EAPA
Laura Dashner CEO & President and Sandra Serrano Chief Development Officer are presenting “An Interview with Sandra Sapp: The 2018 DOT Changes Impacting Opioid Testing” at 11:15 AM on October 13th in Minneapolis. The federal DOT regulations expanded the opioid panel […]
On Our Way To EAPA Read More »